The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Oduyebo, Oyinlola O ^a   Anorlu, Rose I ^a   Ogunsola, Folasade T ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; COMPUTER PROGRAM; COMPUTER SYSTEM; HEALTH CARE DELIVERY; INTERVENTION STUDY; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PATIENT CARE; POINT OF CARE TESTING; QUALITY CONTROL; REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 70049087949     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006055.pub2     Document Type: Review

References (88)

1. Andres FJ, Parker R, Hosein I, Benrubi GI. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: A prospective double -blind clinical trial. Southern Medical Journal 1992;85(11):1077-1080
2. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce A, Reid G. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC -14: randomised, double blind, placebo controlled trial. Microbes and Infection 2006;8(6):1450-1454 (Pubitemid 43903313)
3. Anukam K, Osazuwa E, Osemene G, Ahonkhai I, Ehigiagbe F, Bruce A, Reid G. Clinical study comparing probiotic Lactobacillus GR-1 and RC -14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes and Infection 2006;8(12-13):2772-2776 (Pubitemid 44692555)
4. Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL. Antimicrobial resistance associated with the treatment of bacterial vaginosis. American Journal of Obstetrics and Gynecology 2004;191:1124-1129 (Pubitemid 39421560)
5. Buranawarodomkul P, Chandeying V, Sutthijumroon S. Seven day metronidazole versus single dose tinidazole as therapy for non-specific vaginitis. Journal of the Medical Association of Thailand 1990;73:283-287 (Pubitemid 20324744)
6. * Chaithongwongwatthana S, Limpongsanurak S, Sitthi-Amorn C. Single hydrogen peroxide vaginal douching versus single dose oral metronidazole for the treatment of bacterial vaginosis: a randomised controlled study. Journal of the Medical Association of Thailand 2003; 86 Suppl 2:379-384
7. Eriksson K, Carlsson B, Forsum U, Larsson PG.A double blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovule. Acta Dermato Venereologica 2005;85:42-46 (Pubitemid 40254678)
8. Fischbaach F, Peterson EE, Weissenbacher ER, Martius J, Hossmann J, Mayer H. Efficacy of clindamycin vaginal creamversus oral-metronidazole in the treatment of bacterial vaginosis. Obstetrics and Gynecology 1993;82:405-410 (Pubitemid 23251362)
9. Gerli S, Rossetti D, Di Renzo GC. A new approach for the treatment of bacterial vaginosis: use of polyhexamethylene biguanide. A prospective randomised study. European Review for Medical and Pharmacological Sciences 2003;7:127-130 (Pubitemid 38659935)
10. Greaves WL, Chungafung J, Morris B, Haile A, Townsend JL. Clindamycin versusmetronidazole in the treatment of bacterial vaginosis. Obstetrics and Gynecology 1988;72:799-802. (Pubitemid 18254463)
11. Livengood CH, Thomason JL, Hill GB. Bacctterial vaginosis: Treatment with topical intravaginal clindamycin phosphate. Obstetrics and Gynaecology 1990;76:1.
12. McCormack WM, Covino JM, Thomason JL, Eschenbach DA, Mou S, Kaperick P, et al.Comparison of clindamycin phosphate vaginal cream with triple sulphonamide vaginal cream in the treatment of bacterial vaginosis. Sexually Transmitted Diseases 2001;28:569-575 (Pubitemid 32937565)
13. Milani M, Barcellona E, Agnello A. Efficacy of the combination of 2g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: A randomised, investigator blinded, controlled trial. European Journal of Obstetrics, Gynaecology, and Reproductive Biology 2003;109:62-71. (Pubitemid 36724644)
14. * Nunez JT, Gomez G. Low-dose secnidazole in the treatment of bacterial vaginosis. International Journal of Gynaecology and Obstetrics 2005;88:281-285
15. Paavonen J, Mangioni C, Martin MA, Wajszczuk CP. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: A randomised trial. Obstetrics and Gynecology 2000;96:256-260 (Pubitemid 30447349)
16. Piot P, Van Dyck E, Godts P, Vanderheyden. A placebo-controlled, double blind comparison of tinidazole and triple sulphonamide cream for the treatment of non-specific vaginitis. American Journal of Obstetrics and Gynecology 1983;147:85-89
17. Schinder EM, Thamm H, Ansmann EB, Sarnow E, Schinder AE. Treatment of bacterial vaginosis. Fortschritte der Medizin 1991;109:138-140
18. Scmitt C, Sobel JD, Meriwhether C. Bacterial vaginosis: Treatment with clindamycin cream versus oral metronidazole. Obstetrics and Gynecology 1992;79:1020-1023
19. Schwebke JR. Asymptomatic bacterial vaginosis: Response to therapy. American Journal of Obstetrics and Gynecology 2000;183:1434-1439
20. * Schwebke JR, Desmond RA. A randomised trial of the duration of therapy with me tronidazole plus orminus azithromycin for treatment of symptomatic bacterial vaginosis. Clinical Infectious Diseases 2007;44:213-219
21. Sobel J, Peipert JF, McGregor JA, Livengood C, Matin M, Robbins J, et al.Efficacy of clindamycin vaginal ovule (3 day) treatment versus clindamycin vaginal cream 7 day treatment in bacterial vaginosis. Infectious diseases Obstetrics and Gynecology 2001;9:9-15. (Pubitemid 32510019)
22. Stein GE, Christensen SL, Mummaw NL, Soper DE. Placebo-controlled trrial of intravaginal clindamycin 2% cream for the treatment of bacterial vaginosis. The Annals of Pharmacotherapy 1993;27:1343-1345 (Pubitemid 23336342)
23. Voorspoels J, Casteels M, Renion JP, Temmerman M. Local treatment of bacterial vaginosis with a bioadhesive metronidazole tablet. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2002;105:64-66 (Pubitemid 35335322)
24. Wathne B, Hovelius B, Holst E. Cefadroxil as alternative to metronidazole in the treatment of bacterial vaginosis. Scandinavian Journal of Infectious Diseases 1989;21:585-586 (Pubitemid 19263013)
25. Andreeva P, Slavchev B, Kovachev S, Nacheva A, Vatcheva R. Treatment of Bacterial vaginosis with high dosage metronidazole and lactic acid. Akusherstvo i Ginekologiia 2002;41(5):36-39
26. Blackwell AI, Fox AR, Phillips I, Barlow D.Anaerobic vaginosis (non-specific vaginitis): clinical, microbiological and therapeutic findings. Lancet 1983;2:1379-1383 (Pubitemid 14247682)
27. Eschenbach DA, Crithlow CW, Watkins A. A dose duration study of metronidazole for the treatment of non-specific vaginosis. Scandinavian Journal of Infectious Diseases 1983;40 Suppl:73-80.
28. Facchin S, Grasso A, Guanni E, Mega M. Bacterial vaginosis: New clinical approach [La vaginosi]. Giornale Italiano di Ostetrica e Ginecologica 1995;17(4):241-244
29. Ferris DG, Litaker MS, Woodward L, Mathis D, Hendrick J. Treatmet of bacaterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel and clindamycin vaginal cream. Journal of Family Practice 1995;41(5):443-449
30. Fredricsson B, Hagstrom B, Moller AK, Nord CE. Bacterial vaginosis treated with metronidazole: effects on the vaginal microbial flora by a single dose versus a five day regimen. Zentralblatt fur Gynakologie 1986;108:799-804. (Pubitemid 16068325)
31. Hagstrom B, Lindestedt J. Comparison of two different regimens of metronidazole in the treatment of non-specific vaginitis. Scandinavian Journal of Infectious Diseases 1983;40:95-96 (Pubitemid 14201787)
32. Hovick P.Non-specific vaginitis in an outpatient clinic. Scandinavian Journal of Infectious Diseases 1983;40 Suppl:107-110
33. Improda L, Nobler L, Chierego C, Iacono A, Sica C, Rullo F. Is it necesary to treat the partner of woman affected by bacterial vaginosis. Gior It Osst Gin 1994;78:371-373 (Pubitemid 24283931)
34. Jerve F, Berdal TB, Boham P.Metronidazole in the treatment of non-specific vaginitis. British Journal of Venereal Disease 1984;60:171-174 (Pubitemid 14088173)
35. Jones BM, Geary I, Alawattegama AB, Kinghorn GB, Duerden BI. In- vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis. Journal of Antimicrobial Chemotherapy 1985;16:189-197 (Pubitemid 15002459)
36. Kira EF. Local application of clindamycin phosphate in therapy of bacterial vaginosis. Akusherstvo i Ginekologiia 1994;70(5):53-55
37. Lefevre JC. Bacterial vaginosis (non -specific vaginitis): clinical and bacteriological data [Vaginose bacterienne (vaginite non specique) donnees cliniques et bacteriologiques]. Feuillets de Biologie 1985; XXVi(147):49-52.
38. Linhares. Bacterial vaginosis: experience with thiamphenicol; clue cell [Vaginose bacteriana: experiencia com o tianfenicol]. Journal Brasiliero et Ginecologia 1995;105(9):405-409
39. Malouf M, Fortier M, Morin G, Dube JL.Treatment of Haemophilus vaginalis vaginitis. Obstetrics and Gynecology 1981;57:711-714
40. * Martins NV. Ambulatory diagnosis of vaginitis: evaluation of 4903 patients treated with tinidazole with a single oral dose. Revista Brasileira de Clínica Terapêutica 1985;14:94-98
41. Milankovis M, Laszio B, Janos P. Comparative study of combined local treatment and the standardmonotherapy of uncomplicated bacterial vaginsis [Szovodmenymentes bakterialis vaginosis kombinalt huvelyi kezelesenek (szulfadimidin, metronidazole es nystatin) es a standard monoterapiak osszehasonlito vizsgalata]. Orvosi Hetilap 2002;143(51):2835-2840
42. Mohanty KC, Dieghton R. Comparison of 2g single dose of metronidazole, nimorazole and tinidazole in the treatment of vaginitis associated with Gadnerella vaginalis. Journal of Antimicrobial Chemotherapy 1987;19:393-399
43. Naud P, Matos J, Hammes L, Magno V, Browers C, Spilki M, et al.Efficacy and tolerability of fenticonazole for bacterial vaginosis [Estudo da eficacia e tolerabilidade do ffenticonazole no tratamento da vaginose bacteriana - Estudo duplo-cego, randomizado, prospectivo, controlado e comparado com grupo placebo]. Revista Brasileira de Medicina 2003;60(42):67-70.
44. Purdon A, Hanna JH, Morse PL, Paine DD, Engelkirk PG. An evaluation of single dose metronidazole treatment for Gardnerella vaginalis vaginitis. Obstetrics and Gynecology 1984;64:271-274 (Pubitemid 14096707)
45. Sanchez S, Garcia PJ, Thomas KK, Catlin M, Holmes KK. Intravaginal metronidazole gel versus metronidazole plus nystatin ovule for bacterial vaginosis. American Journal of Obstetrics and Gynecology 2004;191:1898-1906
46. Sanz F, Vidriales I, Callejo C, Rodriguez-Noriega A. 2% Clindamycin intravaginal cream in bacterial vaginosis treatment [Clindamicina, crema intravaginal al 2%en el tratamiento de la vaginosis bacteriana]. Progressos de Obstetricia y Ginecologia 1995;38(5):333-338
47. Sanz Sanz F, Hernanz AD, Sanchez EA, Alvarez CG, Noriega AR. Double-blind randomised comparative trial: Ornidazole (Tiberial) versus Tinidazole (Fasigin) for the treatment of non-specific vaginitis. Chemoterapia 1985;iv(3):218-311 (Pubitemid 15062303)
48. Sanz Sanz F, Hernanz AD, Sanchez EA, Alvarez CG, Muelas M, Rodriguez-Noriega. Controlled comparative study of metronidazole (flagyl) versus tinidazole (Tricolan) in the treatment of non-specific vaginitis (vaginitis due to Gardnerella vaginalis). Revista Espanola de Obstetricia y Ginecologia 2001;44:3-10.
49. Sobel JD, Schmitt C, Meriwhether C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. The Journal of Infectious Diseases 1993;167:783-784 (Pubitemid 23056363)
50. Swedberg J, Steiner JF, Deiss F, Steiner S, Driggers DA. Comparison of single dose versus one course of metronidazole for symptomatic bacterial vaginosis. JAMA 1985;254:1046-1049 (Pubitemid 15012824)
51. Van Der Meijden. Treatment of non-specific vaginitis with a single dose of tinidazole. Scandinavian Journal of Infectious Diseases 1983; 40 Suppl:85-89
52. * Vutyavanich T, Pongsuthirak P, Vannareumol P, Ruangsri R, Luangsook P. A randomised double blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology 1993;82(4):550-554
53. Wei H, Xiaotang Z, Xiuting H, Ying P, Yong S, Lin Q, et al.Clindamycin soluble suppository production and its efficacy in treating bacterial vaginosis. J WCUMS 2001;32(3):452-453 (Pubitemid 32834791)
54. Wilson JD, Carson CF, Wellard SJ, Riley TV. A randomised single blind (investigator blinded) study of intravaginal tea tree oil gel versus intravaginalmetronidazole gel in the treatment of bacterial vaginosis. Proceedings of the 16th Biennielmeeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR). 2005.
55. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenback D, Holmes KK. Diagnostic criteria and microbial and epidemiologic associations. American Journal of Medicine 1983;74(1):14-22.
56. Andreeva P, Slavchev B, Kovschev S, Nachevz A, Vacheva R. Treatment of bacterial vaginisos with high dosage metronidazole and lactic acid [Lechenie na bakteialnata vaginoza s visokodoziran vaginalen metronidazole i mlechna kiselina]. Akusherstvo i Ginekologiia 2002;41(5):36-39
57. Bakare RA, Oni AA, Umar S, Adewole IF, Shokunbi WA, Fayemiwo SA. Pattern of STDs among commercial sex workers (CSWs) in Ibadan, Nigeria. African Journal of Medical Sciences 2002;31(3):243-247
58. Baylson FA, Nyirjesy P, Weitz MV. Treatment of recurrent bacterial vaginosis with tinidazole. Obstetrics and Gynecology 2004;104:931-932 (Pubitemid 40458753)
59. Begum A, Nihifar S, Akther K, Rhaman R, Khatoun F, Rahman M. Prevalence of selected reproductive tract infections among pregnant women attending an urban maternal and childcare unit in Dhaka Bangladesh. Journal of Health Population and Nutrition 2003;21(2):112-116 (Pubitemid 37080704)
60. Bhaduri S, Riley VC.Metronidazole hypersensitivity in a patient with bacterial vaginosis. International Journal of STD and AIDS 1997;8(1):57-58 (Pubitemid 27072830)
61. Covino JM, Black JR, Cummings M, Zwickl B, McCormack WM. Comparative evaluation of ofloxacin and metronidazole in the treatment of bacterial vaginosis. Sexually Transmitted Diseases 1993;20(5):262-264 (Pubitemid 23286954)
62. Dan M, Kaneh N, Levin D, Poch F. Samra F. Vaginitis in a gynaecologic practice in Israel: causes and risk factors. Israel Medical Association Journal 2003;5(9):629-632 (Pubitemid 37203530)
63. Eschenbach DA, Davick PR, Williams BL, Klebanoff SJ, Young-Smith K, Critchlow CM, et al.Prevalence of hydrogen peroxide - producing Lactobacillus species in normal women and women with bacterial vaginosis. Journal of Clinical Microbiology 1989;27:251-256 (Pubitemid 19041152)
64. Guaschino S, Ricci E, Franch M, Frate GD, Tibaldi C, Santo DD, et al.Treatment of asymptomatic bacterial vaginosis to prevent pre term delivery: a randomized trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2003;110(2):149-152 (Pubitemid 37101310)
65. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994;308(6924):295-298 (Pubitemid 2022345)
66. Hill GB, Eschenbach DA, Holmes KK. Bacteriology of the vagina. Scandinavian Journal of Urolology and Nephrology 1984;86 Suppl:23-29
67. Hillier SL, Lipinski C, Briselden AM, Eschenbach DA. Efficacy of intraviginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. Obstetrics and Gynecology 1993;81(6):963-967 (Pubitemid 23168742)
68. Hillier S. In: Holmes KK, Mardh PA, Sparhry PF editor(s). Sexually Transmitted Diseases. 3rd Edition. New York: McGraw-Hill, 1999.
69. Joesoef MR, Schmid GP. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clinical Infectious Diseases 1995;20 Suppl 1:72-79
70. Joesoef MR, Schmid GP, Hillier SL. Bacterial Vaginosis: Review of treatment options and potential clinical indications for therapy. Clinical Infectious Diseases 1999;28 Suppl 1:57-65.
71. Joesoef MR, Schmid GP. Bacterial vaginosis. Journal of Clinical Evidence 1999;1:372-377
72. Klebanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM. Control of the microbial flora of the vagina by H202 generating Lactobacilli. Journal of Infectious Diseases 1991;164:94-100.
73. Larsson PG, Platz-Christensen JJ, Thejls H, Forsum U, Pahlson C. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double blind randomized study. American Journal of Obstetrics and Gynecology 1992;166:100-103
74. Laurent C, Seck K, Coumba N, Kane T, Samb N, Wade A, et al.Prevalence of HIV and other sexually transmitted infections, and risk behaviours in unregistered sex workers in Dakar, Senegal. AIDS 2003;17(12):1811-1816 (Pubitemid 37000099)
75. Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslein P. Bacterial vaginosis as a risk factor for pre-term delivery: a meta analysis. American Journal of Obstetrics and Gynecology 2003;189(1):139-147 (Pubitemid 36886539)
76. Lugo-Miro VI, Green M, Mazur L. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis. JAMA 1992;268(1):92-95
77. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B. Vaginal Lactobacilli, microbial flora and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisiton. Journal of Infectious Diseases 1999;180:1863-1868
78. McDonald H, Brocklehurst P, Parsons J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database of Systematic Reviews 2005, Issue 1.[Art. No.: CD000262. DOI: 10.1002/14651858.CD000262.pub3]
79. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of Clinical Microbiology 1991;29(2):297-301.
80. Priestley CF, Jones BM, Dhar J, Goodwin L. What is normal vaginal flora?. Genitourinary Medicine 1997;73:23-28
81. Ramsay C. How do you include trials with more than two groups into a single metaanalysis?. http/www.epoc.uottawa.ca/FAQmultiplegroups2003.pdf (Accessed: 17/02/2005).
82. Riedner G, Rusizoka M, Hoffmann O, Nichombe F, Lyamuya E, Mmbando D, et al.Baseline survey of sexually transmitted infections in a cohort of female bar workers in Mbeya region Tanzania. Sexually Transmitted Infections 2003;79(5):382-387 (Pubitemid 37330305)
83. Saracoglu F, Gol K, Sahin I, Turkkani B, Atalay C, Oztopcu C. Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole. International Journal of Gynaecology and Obstetrics 1998;62(1):59-61. (Pubitemid 28342638)
84. Soper DE. Bacterial vaginosis and postoperative infections. American Journal of Obstetrics and Gynecology 1993;169:1-9.
85. Spiegel CA, Amsel R, Holmes KK.Diagnosis of bacterial vaginosis by a direct gram stain of vaginal fluid. Journal of Clinical Microbiology 1983;18:170-177
86. Tosun I, Aydin F, Kaklikkaya N, Yazici Y. Frequency of bacterial vaginosis among women attending for intrauterine device insertion at an inner-city family planning clinic. European Journal of Contraceptives and Reproductive Health Care 2003;8(3):135-138 (Pubitemid 37372405)
87. Trexler MF, Fraser TG, Jones MP. Fulminant pseudomembranous colitis caused by clindamycin phosphate vaginal cream. American Journal of Gastroenterology 1997;92(11):2112-2113
88. Wilson JD, Carson CF, Wellard SJ, Riley TV. A randomised single blind (investigator-blinded) study of intravaginal tea tree oil gel versus intravaginal metronidazole gel in the treatment of bacterial vaginosis (BV). Proceedings of the 16th biennial meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR). 2005:308.